新一代测序（NGS）让研究人员和药物开发人员能够更好地了解推动癌症易感性和增殖的生物学。这些见解已促使靶向治疗方案的开发和多分析物的肿瘤分析。反过来，它又打开了新方法的大门，有助于监控癌症治疗和复发。
Illumina通过提供全面的基因组学解决方案并与领先的制药厂商合作，将创新引入肿瘤药物的开发。
希望收到有关药物开发基因组学的快讯、案例研究和信息？请输入您的电子邮箱地址。
Read an interview with John Leite, VP of Marketing for Illumina’s Oncology business.
An overview of exciting new fields of immunotherapy research, and how NGS helps to move them forward.
Read how Merck Serono uses NGS for cell line stability testing and biosafety monitoring.
Explore services and service providers for a broad range of genotyping, gene expression, and sequencing applications.
Reflect what the power of the genome means for drug development and share it. Educate others. Promote the promise of the genome.
